Solid dispersions of drugs in hyaluronan matrix: The role of the biopolymer in modulating drug activity in vivo

Abstract : It was demonstrated in this study that the treatment of physical mixtures of hyaluronic acid (HA) and oncology drugs raloxifene, letrozole, and irinotecan in solid state under shear stress and deformation induces amorphization of the drug component. Such loss of crystallinity favors dispersion of drugs in HA matrix at a molecular level. Upon dissolution, the composites of poorly soluble raloxifene and letrozole form various solvated species that may include drug-HA composites, large agglomerates, and possibly free drug nanoparticles. Amorphous character of drug component and their stabilization in solution by HA leads to improved oral bioavailability of raloxifene and letrozole, but not irinotecan, as demonstrated in pharmacokinetics studies in rats.
Type de document :
Article dans une revue
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2017, 39, pp.140 - 146. 〈10.1016/j.jddst.2017.03.018〉
Liste complète des métadonnées

https://hal-riip.archives-ouvertes.fr/pasteur-01574615
Contributeur : Michel Courcelles <>
Soumis le : mardi 15 août 2017 - 22:16:17
Dernière modification le : vendredi 13 octobre 2017 - 17:13:26

Identifiants

Collections

Citation

Kirill I. Shingel, Mikhail Selyanin, Mario C. Filion, Felix Polyak. Solid dispersions of drugs in hyaluronan matrix: The role of the biopolymer in modulating drug activity in vivo. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2017, 39, pp.140 - 146. 〈10.1016/j.jddst.2017.03.018〉. 〈pasteur-01574615〉

Partager

Métriques

Consultations de la notice

10